| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06698003 | A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1 | T-Cell Leukemia/Lymphoma, Adult | Recruiting |
| NCT05996185 | Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma | T Cell Lymphoma | Recruiting |
| NCT05956041 | Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell… | Cutaneous T Cell Lymphoma | Recruiting |
| NCT07529405 | A Study of VG712 in Patients With Mycosis Fungoides | Mycosis Fungoides | Not Yet Recruiting |
| Phase 1 | |||
| NCT04848064 | Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or… | Recurrent Adult T-Cell Leukemia/Lymphoma | Recruiting |
| NCT05414500 | Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides | Cutaneous T Cell Lymphoma | Recruiting |